Consistent with human genetic findings, liver-specific Tm6sf2-deficient mice show significantly reduced TC and TG levels and VLDL particle size [10,11] while exhibiting spontaneous hepatic steatosis, fibrosis, and accelerated development of hepatocellular cancer [13]. The gene discussed is TM6SF2; the disease is Hepatic steatosis.